Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02837211 · ClinicalTrials.gov registry record · NA

The TREND Study: Tapered Reduction in Energy Intake as a Novel Approach to Dieting

A NA study of Obesity, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT02837211: Completed NA study of Obesity, sponsored by Wake Forest University Health Sciences.

NCT02837211 is a NA study of Obesity that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 22 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02837211, a NA study of Obesity, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

TREND is a pilot randomized trial comparing two alternative methods of initiating a low-calorie weight loss diet. The study will compare the traditional diet initiation of abruptly dropping energy intake to 1000 kcal/day for women and 1200 kcal/day for men versus a 6 week tapering of energy intake from a baseline level. These two approaches will be compared with respect to their impact on energy regulatory systems of the body, weight loss and other measures, up to a year after diet initiation.

Primary Outcome

Orexogenic hormone

Conditions Studied

Interventions

  • BEHAVIORAL Tapered Low Calorie Diet
  • BEHAVIORAL Traditional Low-Calorie Diet

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2016-08
Est. Completion 2018-05-11
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT02837211 record still lists

NCT02837211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Tapered Low Calorie Diet is the first listed.

NCT02837211 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02837211 about?

NCT02837211 is a clinical study titled "The TREND Study: Tapered Reduction in Energy Intake as a Novel Approach to Dieting". TREND is a pilot randomized trial comparing two alternative methods of initiating a low-calorie weight loss diet. The study will compare the traditional diet initiation of abruptly dropping energy intake to 1000 kcal/day for women and 1200 kcal/day for men versus a 6 week tapering of energy intake f...

What is the current status of trial NCT02837211?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-08. Estimated completion is 2018-05-11.

What conditions does trial NCT02837211 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02837211?

The interventions under investigation include: Tapered Low Calorie Diet (BEHAVIORAL), Traditional Low-Calorie Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT02837211?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02837211 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02837211's enrollment target sits among peer trials

22 935th of 1053 higher than 116 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02837211, the US trial registry maintained by the National Library of Medicine. NCT02837211 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.